Investment Advisory Group’s AbbVie ABBV Stock Holding History

Investment Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Buy	4,857 +162	+3%	+$35.9K	0.27%	75
2025 Q4	$1.07M	Hold	4,695	–	–	0.28%	70
2025 Q3	$1.09M	Hold	4,695	–	–	0.3%	68
2025 Q2	$871K	Buy	4,695 +292	+7%	+$54.3K	0.26%	74
2025 Q1	$922K	Buy	4,403 +49	+1%	+$9.53K	0.31%	68
2024 Q4	$774K	Buy	4,354 +23	+0.5%	+$4.23K	0.26%	73
2024 Q3	$855K	Buy	4,331 +567	+15%	+$106K	0.3%	69
2024 Q2	$646K	Sell	3,764 -11	-0.3%	-$1.82K	0.25%	77
2024 Q1	$687K	Buy	3,775 +26	+0.7%	+$4.48K	0.28%	72
2023 Q4	$581K	Sell	3,749 -17	-0.5%	-$2.48K	0.27%	73
2023 Q3	$561K	Buy	3,766 +48	+1%	+$7.05K	0.29%	68
2023 Q2	$501K	Sell	3,718 -80	-2%	-$11.7K	0.26%	77
2023 Q1	$605K	Hold	3,798	–	–	0.35%	62
2022 Q4	$614K	Hold	3,798	–	–	0.38%	55
2022 Q3	$510K	Hold	3,798	–	–	0.35%	61
2022 Q2	$581K	Hold	3,798	–	–	0.4%	51
2022 Q1	$614K	Hold	3,798	–	–	0.37%	56
2021 Q4	$542K	Buy	+3,798	New	+$449K	0.35%	58

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Investment Advisory Group's ABBV Position: Q1 2026 in Review

Investment Advisory Group increased its AbbVie (ABBV) stake by 3.5% in Q1 2026, buying an estimated $35.9K and bringing the position to 4,857 shares worth $1.06M. The position accounts for 0.27% of the portfolio, ranked #75.

Investment Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.09M in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Investment Advisory Group held 4,857 shares of AbbVie worth $1.06M as of Q1 2026.
Investment Advisory Group bought 162 AbbVie shares in Q1 2026, an estimated $35.9K.
AbbVie made up 0.27% of Investment Advisory Group's portfolio in Q1 2026, its #75 holding.
Investment Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
Investment Advisory Group's AbbVie position peaked at $1.09M in Q3 2025.
4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Investment Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.